Biomarker - Panitumumab Response With KRAS Wild Type MCC
Clinical trial NCT00853931 · COMPLETED
Trial details
- NCT number
- NCT00853931
- Sponsor
- British Columbia Cancer Agency
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2015-09-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.